AN2 Therapeutics Stock Forecast - Daily Balance Of Power

ANTX Stock  USD 1.43  0.05  3.38%   
AN2 Stock Forecast is based on your current time horizon.
  
Payables Turnover is likely to drop to 0.03 in 2024. Common Stock Shares Outstanding is likely to drop to about 21.8 M in 2024. Net Loss is likely to drop to about (40.4 M) in 2024.
On December 6, 2024 AN2 Therapeutics had Daily Balance Of Power of 0.375. Balance of Power indicator (or BOP) measures the strength of AN2 Therapeutics market sensitivity to bulls and bears. It estimates the ability of AN2 Therapeutics buyers and sellers to push price to an extreme high or extreme low level. As a result, by monitoring AN2 Therapeutics Balance of Power indicator one can determine a trend of the price direction.
Check AN2 Therapeutics VolatilityBacktest AN2 TherapeuticsTrend Details  

AN2 Therapeutics Trading Date Momentum

On December 09 2024 AN2 Therapeutics was traded for  1.42  at the closing time. The top price for the day was 1.50  and the lowest listed price was  1.40 . The trading volume for the day was 229.5 K. The trading history from December 9, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 1.39% . The overall trading delta against the current closing price is 9.03% .
Balance of Power indicator was created by Igor Livshin to predict asset short term price movements or warning signals. If Balance of Power indicator is trended towards the high of its range it will signify that the bulls are in control. On the other hand when the BOP indicator is moving towards the lows of its range it signifies that the bears are in control. If the indicator move from a high positive range to a lower positive range it signifies that the buying pressure is decreasing. Conversely, if the indicator move from a low negative range to a higher negative range it signifies that the selling pressure is decreasing.
Compare AN2 Therapeutics to competition

Other Forecasting Options for AN2 Therapeutics

For every potential investor in AN2, whether a beginner or expert, AN2 Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. AN2 Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in AN2. Basic forecasting techniques help filter out the noise by identifying AN2 Therapeutics' price trends.

AN2 Therapeutics Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with AN2 Therapeutics stock to make a market-neutral strategy. Peer analysis of AN2 Therapeutics could also be used in its relative valuation, which is a method of valuing AN2 Therapeutics by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

AN2 Therapeutics Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of AN2 Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of AN2 Therapeutics' current price.

AN2 Therapeutics Market Strength Events

Market strength indicators help investors to evaluate how AN2 Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading AN2 Therapeutics shares will generate the highest return on investment. By undertsting and applying AN2 Therapeutics stock market strength indicators, traders can identify AN2 Therapeutics entry and exit signals to maximize returns.

AN2 Therapeutics Risk Indicators

The analysis of AN2 Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in AN2 Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting an2 stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for AN2 Stock Analysis

When running AN2 Therapeutics' price analysis, check to measure AN2 Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AN2 Therapeutics is operating at the current time. Most of AN2 Therapeutics' value examination focuses on studying past and present price action to predict the probability of AN2 Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AN2 Therapeutics' price. Additionally, you may evaluate how the addition of AN2 Therapeutics to your portfolios can decrease your overall portfolio volatility.